Longitudinal assessment of gray matter volumes and white matter integrity in patients with medication-overuse headache

Abstract

Background

Medication-overuse headache is a common clinical entity, but neuroimaging studies investigating volumetric and microstructural alterations of the brain in medication-overuse headache are rare. Therefore, in the current longitidunal study we evaluated gray matter volume and white matter integrity in patients with medication-overuse headache before and after drug withdrawal.

Methods

A prospective study evaluated 27 patients with medication-overuse headache and 27 age-, sex-, and education-matched healthy adults. High-resolution T1-weighted magnetic resonance imaging and diffusion tensor imaging were obtained from the control group and medication-overuse headache patients before and six months after drug withdrawal. Tract-based spatial statistics of multiple diffusivity indices and voxel-based morphometry were employed to investigate white and gray matter abnormalities.

Results

No correlation was found between age, gender, education and smoking status in both groups. The most commonly overused medications were simple analgesics (96.3%) and combined analgesics (3.7%). The mean duration of the history of medication overuse and headaches was 56.7 ± 63.5 months. White matter diffusional and gray matter morphological alterations including volume, fractional anisotropy, radial diffusivity, and axial diffusivity analyses showed no significant relationship in the patients before and six months after withdrawal of analgesics. Also no difference was observed between the patients versus controls.

Conclusion

Our data demonstrated no structural alterations within the brain in medication-overuse headache.

Keywords

Diffusion tensor imaging medication-overuse headache voxel-based morphometry

Get full access to this article

View all access options for this article.

References

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629–808.

Diener

Holle

Solbach

et al.

Medication-overuse headache: Risk factors, pathophysiology and management. Nat Rev Neurol 2016; 12: 575–584.

Heyer

Idris

. Does analgesic overuse contribute to chronic post-traumatic headaches in adolescent concussion patients? Pediatr Neurol 2014; 50: 464–468.

Castillo

Muñoz

Guitera

et al.

Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 1999; 39: 190–196.

Prencipe

Casini

Ferretti

et al.

Prevalence of headache in an elderly population: Attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry 2001; 70: 377–381.

Lantéri-Minet

Auray

El Hasnaoui

et al.

Prevalence and description of chronic daily headache in the general population in France. Pain 2003; 102: 143–149.

Colás

Muñoz

Temprano

et al.

Chronic daily headache with analgesic overuse: Epidemiology and impact on quality of life. Neurology 2004; 27: 1338–1342.

Straube

Pfaffenrath

Ladwig

et al.

Prevalence of chronic migraine and medication overuse headache in Germany—The German DMKG headache study. Cephalalgia 2010; 30: 207–213.

Lai

Protsenko

Cheng

et al.

Neural plasticity in common forms of chronic headaches. Neural Plast 2015; 2015: 205985.

10.

De Felice

Ossipov

Porreca

. Persistent medication-induced neural adaptations, descending facilitation, and medication overuse headache. Curr Opin Neurol 2011; 24: 193–196.

11.

May

. Chronic pain may change the structure of the brain. Pain 2008; 137: 7–15.

12.

Ashburner

Friston

. Why voxel-based morphometry should be used. Neuroimage 2001; 14: 1238–1243.

13.

Riederer

Marti

Luechinger

et al.

Grey matter changes associated with medication-overuse headache: Correlations with disease related disability and anxiety. World J Biol Psychiatry 2012; 13: 517–525.

14.

Riederer

Gantenbein

Marti

et al.

Decrease of gray matter volume in the midbrain is associated with treatment response in medication overuse headache: Possible influence of orbitofrontal cortex. J Neurosci 2013; 33: 15343–15349.

15.

Chanraud

Di Scala

Dilharreguy

et al.

Brain functional connectivity and morphology changes in medication-overuse headache: Clue for dependence-related processes?

Cephalalgia 2014; 34: 605–606.

16.

Beckmann

Gelal

Eren

et al.

Diagnostics to look beyond the normal appearing brain tissue (NABT)? A neuroimaging study of patients with primary headache and NABT using magnetization transfer imaging and diffusion magnetic resonance. Clin Neuroradiol 2013; 23: 277–283.

17.

Rocca

Colombo

Inglese

et al.

A diffusion tensor magnetic resonance imaging study of brain tissue from patients with migraine. J Neurol Neurosurg Psychiatry 2003; 74: 501–503.

18.

Yuan

Zhao

et al.

White matter integrity affected by depressive symptoms in migraine without aura: A tract-based spatial statistics study. NMR Biomed 2013; 26: 1103–1112.

19.

Basser

Pierpaoli

. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996; 111: 209–219.

20.

Michels

Christidi

Steiger

et al.

Pain modulation is affected differently in medication-overuse headache and chronic myofascial pain—A multimodal MRI study. Cephalalgia 2017; 37: 764–779.

21.

Smith

Jenkinson

Woolrich

et al.

Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004; 23: 208–219.

22.

Smith

. Fast robust automated brain extraction. Hum Brain Mapp 2002; 17: 143–155.

23.

Smith

Jenkinson

Johansen-Berg

et al.

Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 2006; 31: 1487–1505.

24.

Douaud

Smith

Jenkinson

et al.

Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 2007; 130: 2375–2386.

25.

Good

Johnsrude

Ashburner

et al.

A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14 (1 Pt 1): 21–36.

26.

Andersson M, Jenkinson S and Smith S. Non-linear registration, aka spatial normalisation. FMRIB TR07JA2, www.fmrib.ox.ac.uk/analysis/techrep (2007, accessed 25 January 2018).

27.

Nichols

Holmes

. Nonparametric permutation tests for functional neuroimaging: A primer with examples. Hum Brain Mapp 2002; 15: 1–25.

28.

Smith

Nichols

. Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localization in cluster inference. Neuroimage 2009; 44: 83–98.

29.

Lai

Chou

Fuh

et al.

Gray matter changes related to medication overuse in patients with chronic migraine. Cephalalgia 2016; 36: 1324–1333.

30.

Schmidt-Wilcke

Leinisch

Straube

et al.

Gray matter decrease in patients with chronic tension type headache. Neurology 2005; 65: 1483–1486.

31.

Bøe

Salvesen

Mygland

. Chronic daily headache with medication overuse: Predictors of outcome 1 year after withdrawal therapy. Eur J Neurol 2009; 16: 705–712.

32.

Bigal

Serrano

Buse

et al.

Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache 2008; 48: 1157–1168.

33.

Srikiatkhachorn

le Grand

Supornsilpchai

et al.

Pathophysiology of medication overuse headache—An update. Headache 2013; 54: 204–210.

34.

De Felice

Ossipov

Wang

et al.

Triptan-induced latent sensitization: A possible basis for medication overuse headache. Ann Neurol 2010; 67: 325–337.

35.

Matharu

Good

May

et al.

No change in the structure of the brain in migraine: A voxel-based morphometric study. Eur J Neurol 2003; 10: 53–57.

36.

May

. A review of diagnostic and functional imaging in headache. J Headache Pain 2006; 7: 174–184.

37.

Lutz

Jäger

de Quervain

et al.

White and gray matter abnormalities in the brain of patients with fibromyalgia: A diffusion-tensor and volumetric imaging study. Arthritis Rheum 2008; 58: 3960–3969.

38.

Geha

Baliki

Harden

et al.

The brain in chronic CRPS pain: Abnormal gray-white matter interactions in emotional and autonomic regions. Neuron 2008; 60: 570–581.

39.

Teepker

Menzler

Belke

et al.

Diffusion tensor imaging in episodic cluster headache. Headache 2012; 52: 274–282.

40.

Moayedi

Weissman-Fogel

Salomons

et al.

White matter brain and trigeminal nerve abnormalities in temporomandibular disorder. Pain 2012; 153: 1467–1477.

41.

DaSilva

Granziera

Tuch

et al.

Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine. Neuroreport 2007; 18: 301–305.

42.

Granziera

DaSilva

Snyder

et al.

Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med 2006; 3: e402.

43.

Neeb

Bastian

Villringer

et al.

No microstructural white matter alterations in chronic and episodic migraineurs: A case-control diffusion tensor magnetic resonance imaging study. Headache 2015; 55: 241–245.

44.

Parise

Kubo

Doring

et al.

Cuneus and fusiform cortices thickness is reduced in trigeminal neuralgia. J Headache Pain 2014; 15: 17.

45.

Hagen

Linde

Steiner

et al.

Risk factors for medication overuse headache: An 11-year follow-up study. The Nord-Trøndelag Health Studies. Pain 2012; 153: 56–61.

46.

Fritz

Wittfeld

Schmidt

et al.

Current smoking and reduced gray matter volume—A voxel-based morphometry study. Neuropsychopharmacology 2014; 39: 2594–2600.

47.

Hagen

Vatten

Stovner

et al.

Low socio-economic status is associated with increased risk of frequent headache: A prospective study of 22718 adults in Norway. Cephalalgia 2002; 22: 672–679.

48.

Westergaard

Glümer

Hansen

et al.

Prevalence of chronic headache with and without medication overuse: Associations with socioeconomic position and physical and mental health status. Pain 2014; 155: 2005–2013.